Calamos Advisors’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-512,066
Closed -$5.26M 1021
2023
Q2
$5.26M Hold
512,066
0.03% 561
2023
Q1
$5.19M Hold
512,066
0.03% 614
2022
Q4
$5.1M Hold
512,066
0.02% 650
2022
Q3
$4.98M Buy
+512,066
New +$4.98M 0.02% 686

Other funds holding HWEL

Calamos Advisors's HWEL Position: Q3 2023 in Review

Calamos Advisors sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q3 2023, closing a stake of 512,066 shares — an estimated $5.26M sold.

Calamos Advisors first reported a position in HWEL in Q3 2022 and held it in 4 quarters. The position peaked at $5.26M in Q2 2023. 11 funds tracked by Wall St. Rank hold HWEL as of Q3 2023.

  • Calamos Advisors reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Calamos Advisors sold 512,066 Healthwell Acquisition Corp. I Class A Common Stock shares in Q3 2023, an estimated $5.26M.
  • Calamos Advisors first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q3 2022 and held it in 4 quarters.
  • Calamos Advisors's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $5.26M in Q2 2023.
  • 11 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q3 2023.

Based on Calamos Advisors's 13F filing for Q3 2023, filed 26 Oct 2023.